Similar articles

• [Treatment of dyslipoproteinemia in patients with diabetes mellitus type 2 (non-insulin-dependent)].

  Leowski J. Leowski J. Pol Tyg Lek. 1992 Jan 6-13;47(1-2):43-7. Pol Tyg Lek. 1992. PMID: 1409042 Review. Polish. No abstract available.
• [Dietary treatment of hyperlipoproteinemia. Reduction of atherogenic lipid fractions in normal subjects].

  Weisweiler P. Weisweiler P. Fortschr Med. 1985 Feb 21;103(7):148-50. Fortschr Med. 1985. PMID: 3972329 German. No abstract available.
• [Arteriosclerosis. II. Pathogenesis of dyslipoproteinemia].

  Cybulska B, Kłosiewicz-Latoszek L. Cybulska B, et al. Wiad Lek. 1985 Aug 1;38(15):1097-103. Wiad Lek. 1985. PMID: 4072207 Polish. No abstract available.
• [Vasoprotective and vasoaggressive characteristics of serum lipoproteins].

  Mertz DP. Mertz DP. MMW Munch Med Wochenschr. 1978 Dec 8;120(50):1671-2. MMW Munch Med Wochenschr. 1978. PMID: 214704 German. No abstract available.
• A pediatric approach to atherosclerosis prevention.

  Glueck CJ. Glueck CJ. Curr Concepts Nutr. 1975;3:101-11. Curr Concepts Nutr. 1975. PMID: 165920 Review. No abstract available.